SRF approves ₹180 crore capex to establish PIP-2 pharma intermediate plant at Dahej, with completion targeted by Sep-2026, financed through a mix of debt and internal accruals to tap pharma opportunities.
AI Assistant
SRF Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.